CHIME Study | To meet the WHO HCV elimination goals of 2030, members of priority populations, such as people who use drugs (PWUD), must be identified and engaged in care leading to the provision of HCV therapy.
Presented at the Canadian Liver Meeting. February 28- March 1, Montreal, Canada, 2020.